Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantation
- PMID: 21108329
- DOI: 10.1002/ajh.21889
Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantation
Comment in
-
The importance of correct assignment of CYP2B6 genetic variants with respect to cyclophosphamide metabolizer status.Am J Hematol. 2011 Apr;86(4):383-4; author reply 384. doi: 10.1002/ajh.21987. Am J Hematol. 2011. PMID: 21442647 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
